Ehsanollah Esfandiari M.D.

Ehsanollah Esfandiari, MD PhD, serves as the Global Head of Development Project Strategy & Leadership and Global Head of Immunology R&D at Kyowa Kirin Co., Ltd. since November 2018. Concurrently, Ehsanollah is a Visiting NHS Consultant Physician at Imperial College London, focusing on Renal Medicine and Immunology/Inflammation since 2006. Previous roles include Senior Medical Director at Takeda Pharmaceuticals, Global Director of Clinical Strategy at UCB, Associate Director at AstraZeneca, and Clinical Scientist at Hoffmann-La Roche, with extensive experience in clinical development in immunology, rheumatology, and oncology. Ehsanollah's academic background includes senior positions at various universities and a PhD in Immunology/Rheumatology from the University of Glasgow, complemented by multiple postgraduate degrees in related fields. Ehsanollah has contributed to innovative therapies for joint damage and immune-mediated diseases throughout a distinguished career.